Global Mydriatic Eyedrops Market

Mydriatic Eyedrops Comprehensive Study by Type (Atropine, Mydrilate (Cyclopentolate), Homatropine, Mydriacyl (Tropicamide), Phenylephrine), Application (Infants, Children, Adults), Sales Channel (Medical Stores, Pharmacy, Online Stores), Disease Indication (Iritis Inflammation, Cyclitis, Cycloplegia, Others) Players and Region - Global Market Outlook to 2030

Mydriatic Eyedrops Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 4.7%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
The mydriatic eyedrops are the part of a mydriatic line of medicines that helps in treating the Mydriasis, the eyedrops make the pupil of the eye wide open (dilate). The mydriatics are also used to treat inflammatory eye conditions such as cyclitis, iritis and also it reduces painful paralysis of the ciliary muscle of the eye (cycloplegia). The mydriatic eyedrops such as tropicamide relax the iris sphincter which is innervated by the parasympathetic nervous system. There are also various types of mydriatics available such as phenylephrine, atropine, mydrilate, homatropine and mydriacyl.

Highlights from Mydriatic Eyedrops Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR4.7%


The key Players profiled in the report are Novartis AG (Switzerland), Alcon Laboratories (M) Sdn Bhd (Malaysia), Santen Pharmaceutical Co., Ltd. (Japan), Visine (Johnson & Johnson Consumer Inc.) (United States), Akorn Inc. (United States), Hikma Pharmaceuticals (United Kingdom), Fresenius Kabi (Germany), Cipla Limited (India), Ocuphire Pharma, Inc. (United States), Eyekare Kilitch Ltd. (India) and MOLBASE (Shanghai) Biotechnology Co., Ltd (China). Additionally, other players that are part of this comprehensive study are Manus Aktteva Biopharma LLP (India) and Iwaki Seiyaku Co., Ltd (Japan).

Geographic Breakdown and Segment Analysis
The Global Mydriatic Eyedrops market presents a comprehensive analysis of the Mydriatic Eyedrops market by product type (Atropine, Mydrilate (Cyclopentolate), Homatropine, Mydriacyl (Tropicamide) and Phenylephrine), by end-user/application (Infants, Children and Adults), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Mydriatic Eyedrops industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Mydriatic Eyedrops market

Analyst at AMA have segmented the market study of Global Mydriatic Eyedrops market by Type, Application and Region.

Influencing Trend:
Increasing Number of Licence Approvals for Mydriatic Medicines and Continuous Research in Mydriatic Eyedrop Products

Market Growth Drivers:
Growing Number of Genetic Mydriasis Cases to Children and Increasing Issues Due to Chemical Injuries or Wound on Eyes Leading to Dilated Pupils

Challenges:
Proper Labeling and Packaging Mydriatic Eyedrops for Effective Use

Restraints:
Side Effects Associated with Mydriatic Eyedrops and Regulatory Standards on Mydriatic Eyedrops

Opportunities:
Growing Online Sales Channels will Boost the Mydriatic Eyedrops Market and Surging Availability of Mydriatic Eyedrops in Online Channels

Market Developments Activities:

On 1st April 2019, Alcon announced the expansion of Alcaine (proparacaine hydrochloride ophthalmic solution, USP) 0.5% 15mL to its Procedural Eye Drops portfolio, which is made up of mydriatic, cycloplegic, diagnostic and anesthetic products. Alcaine Solution 0.5% 15mL, the only branded proparacaine available, is a topical local anesthetic indicated for corneal anesthesia of short duration, and for short corneal and conjunctival procedures. They offer a complete line of high-quality ophthalmic products to customers. Alcaine Solution 0.5% 15mL has been a trusted solution for surgical and clinical ophthalmic procedures. We hope by offering this product directly from Alcon we will continue to meet the ongoing needs of patients and eye care professionals.



The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market shortly. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period.

Key Target Audience
Mydriatic Eyedrops Manufacturers, Mydriatic Eyedrops International Traders, Mydriatic Eyedrops Distributors and Suppliers, Research and Development Institutes, Potential Investors, Industry Associations, Upstream and Downstream Buyers, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Atropine
  • Mydrilate (Cyclopentolate)
  • Homatropine
  • Mydriacyl (Tropicamide)
  • Phenylephrine
By Application
  • Infants
  • Children
  • Adults
By Sales Channel
  • Medical Stores
  • Pharmacy
  • Online Stores

By Disease Indication
  • Iritis Inflammation
  • Cyclitis
  • Cycloplegia
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Genetic Mydriasis Cases to Children
      • 3.2.2. Increasing Issues Due to Chemical Injuries or Wound on Eyes Leading to Dilated Pupils
    • 3.3. Market Challenges
      • 3.3.1. Proper Labeling and Packaging Mydriatic Eyedrops for Effective Use
    • 3.4. Market Trends
      • 3.4.1. Increasing Number of Licence Approvals for Mydriatic Medicines
      • 3.4.2. Continuous Research in Mydriatic Eyedrop Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Mydriatic Eyedrops, by Type, Application, Sales Channel, Disease Indication and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Mydriatic Eyedrops (Value)
      • 5.2.1. Global Mydriatic Eyedrops by: Type (Value)
        • 5.2.1.1. Atropine
        • 5.2.1.2. Mydrilate (Cyclopentolate)
        • 5.2.1.3. Homatropine
        • 5.2.1.4. Mydriacyl (Tropicamide)
        • 5.2.1.5. Phenylephrine
      • 5.2.2. Global Mydriatic Eyedrops by: Application (Value)
        • 5.2.2.1. Infants
        • 5.2.2.2. Children
        • 5.2.2.3. Adults
      • 5.2.3. Global Mydriatic Eyedrops by: Sales Channel (Value)
        • 5.2.3.1. Medical Stores
        • 5.2.3.2. Pharmacy
        • 5.2.3.3. Online Stores
      • 5.2.4. Global Mydriatic Eyedrops by: Disease Indication (Value)
        • 5.2.4.1. Iritis Inflammation
        • 5.2.4.2. Cyclitis
        • 5.2.4.3. Cycloplegia
        • 5.2.4.4. Others
      • 5.2.5. Global Mydriatic Eyedrops Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Mydriatic Eyedrops (Volume)
      • 5.3.1. Global Mydriatic Eyedrops by: Type (Volume)
        • 5.3.1.1. Atropine
        • 5.3.1.2. Mydrilate (Cyclopentolate)
        • 5.3.1.3. Homatropine
        • 5.3.1.4. Mydriacyl (Tropicamide)
        • 5.3.1.5. Phenylephrine
      • 5.3.2. Global Mydriatic Eyedrops by: Application (Volume)
        • 5.3.2.1. Infants
        • 5.3.2.2. Children
        • 5.3.2.3. Adults
      • 5.3.3. Global Mydriatic Eyedrops by: Sales Channel (Volume)
        • 5.3.3.1. Medical Stores
        • 5.3.3.2. Pharmacy
        • 5.3.3.3. Online Stores
      • 5.3.4. Global Mydriatic Eyedrops by: Disease Indication (Volume)
        • 5.3.4.1. Iritis Inflammation
        • 5.3.4.2. Cyclitis
        • 5.3.4.3. Cycloplegia
        • 5.3.4.4. Others
      • 5.3.5. Global Mydriatic Eyedrops Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Mydriatic Eyedrops (Price)
      • 5.4.1. Global Mydriatic Eyedrops by: Type (Price)
  • 6. Mydriatic Eyedrops: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novartis AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Alcon Laboratories (M) Sdn Bhd (Malaysia)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Santen Pharmaceutical Co., Ltd. (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Visine (Johnson & Johnson Consumer Inc.) (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Akorn Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hikma Pharmaceuticals (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fresenius Kabi (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cipla Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Ocuphire Pharma, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eyekare Kilitch Ltd. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MOLBASE (Shanghai) Biotechnology Co., Ltd (China)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Mydriatic Eyedrops Sale, by Type, Application, Sales Channel, Disease Indication and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Mydriatic Eyedrops (Value)
      • 7.2.1. Global Mydriatic Eyedrops by: Type (Value)
        • 7.2.1.1. Atropine
        • 7.2.1.2. Mydrilate (Cyclopentolate)
        • 7.2.1.3. Homatropine
        • 7.2.1.4. Mydriacyl (Tropicamide)
        • 7.2.1.5. Phenylephrine
      • 7.2.2. Global Mydriatic Eyedrops by: Application (Value)
        • 7.2.2.1. Infants
        • 7.2.2.2. Children
        • 7.2.2.3. Adults
      • 7.2.3. Global Mydriatic Eyedrops by: Sales Channel (Value)
        • 7.2.3.1. Medical Stores
        • 7.2.3.2. Pharmacy
        • 7.2.3.3. Online Stores
      • 7.2.4. Global Mydriatic Eyedrops by: Disease Indication (Value)
        • 7.2.4.1. Iritis Inflammation
        • 7.2.4.2. Cyclitis
        • 7.2.4.3. Cycloplegia
        • 7.2.4.4. Others
      • 7.2.5. Global Mydriatic Eyedrops Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Mydriatic Eyedrops (Volume)
      • 7.3.1. Global Mydriatic Eyedrops by: Type (Volume)
        • 7.3.1.1. Atropine
        • 7.3.1.2. Mydrilate (Cyclopentolate)
        • 7.3.1.3. Homatropine
        • 7.3.1.4. Mydriacyl (Tropicamide)
        • 7.3.1.5. Phenylephrine
      • 7.3.2. Global Mydriatic Eyedrops by: Application (Volume)
        • 7.3.2.1. Infants
        • 7.3.2.2. Children
        • 7.3.2.3. Adults
      • 7.3.3. Global Mydriatic Eyedrops by: Sales Channel (Volume)
        • 7.3.3.1. Medical Stores
        • 7.3.3.2. Pharmacy
        • 7.3.3.3. Online Stores
      • 7.3.4. Global Mydriatic Eyedrops by: Disease Indication (Volume)
        • 7.3.4.1. Iritis Inflammation
        • 7.3.4.2. Cyclitis
        • 7.3.4.3. Cycloplegia
        • 7.3.4.4. Others
      • 7.3.5. Global Mydriatic Eyedrops Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Mydriatic Eyedrops (Price)
      • 7.4.1. Global Mydriatic Eyedrops by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Mydriatic Eyedrops: by Type(USD Million)
  • Table 2. Mydriatic Eyedrops Atropine , by Region USD Million (2018-2023)
  • Table 3. Mydriatic Eyedrops Mydrilate (Cyclopentolate) , by Region USD Million (2018-2023)
  • Table 4. Mydriatic Eyedrops Homatropine , by Region USD Million (2018-2023)
  • Table 5. Mydriatic Eyedrops Mydriacyl (Tropicamide) , by Region USD Million (2018-2023)
  • Table 6. Mydriatic Eyedrops Phenylephrine , by Region USD Million (2018-2023)
  • Table 7. Mydriatic Eyedrops: by Application(USD Million)
  • Table 8. Mydriatic Eyedrops Infants , by Region USD Million (2018-2023)
  • Table 9. Mydriatic Eyedrops Children , by Region USD Million (2018-2023)
  • Table 10. Mydriatic Eyedrops Adults , by Region USD Million (2018-2023)
  • Table 11. Mydriatic Eyedrops: by Sales Channel(USD Million)
  • Table 12. Mydriatic Eyedrops Medical Stores , by Region USD Million (2018-2023)
  • Table 13. Mydriatic Eyedrops Pharmacy , by Region USD Million (2018-2023)
  • Table 14. Mydriatic Eyedrops Online Stores , by Region USD Million (2018-2023)
  • Table 15. Mydriatic Eyedrops: by Disease Indication(USD Million)
  • Table 16. Mydriatic Eyedrops Iritis Inflammation , by Region USD Million (2018-2023)
  • Table 17. Mydriatic Eyedrops Cyclitis , by Region USD Million (2018-2023)
  • Table 18. Mydriatic Eyedrops Cycloplegia , by Region USD Million (2018-2023)
  • Table 19. Mydriatic Eyedrops Others , by Region USD Million (2018-2023)
  • Table 20. South America Mydriatic Eyedrops, by Country USD Million (2018-2023)
  • Table 21. South America Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 22. South America Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 23. South America Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 24. South America Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 25. Brazil Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 26. Brazil Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 27. Brazil Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 28. Brazil Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 29. Argentina Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 30. Argentina Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 31. Argentina Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 32. Argentina Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 33. Rest of South America Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 36. Rest of South America Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 37. Asia Pacific Mydriatic Eyedrops, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 41. Asia Pacific Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 42. China Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 43. China Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 44. China Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 45. China Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 46. Japan Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 47. Japan Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 48. Japan Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 49. Japan Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 50. India Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 51. India Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 52. India Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 53. India Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 54. South Korea Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 55. South Korea Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 56. South Korea Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 57. South Korea Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 58. Taiwan Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 59. Taiwan Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 60. Taiwan Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 61. Taiwan Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 62. Australia Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 63. Australia Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 64. Australia Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 65. Australia Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 70. Europe Mydriatic Eyedrops, by Country USD Million (2018-2023)
  • Table 71. Europe Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 72. Europe Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 73. Europe Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 74. Europe Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 75. Germany Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 76. Germany Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 77. Germany Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 78. Germany Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 79. France Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 80. France Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 81. France Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 82. France Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 83. Italy Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 84. Italy Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 85. Italy Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 86. Italy Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 87. United Kingdom Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 88. United Kingdom Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 90. United Kingdom Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 91. Netherlands Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 92. Netherlands Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 93. Netherlands Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 94. Netherlands Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 95. Rest of Europe Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 98. Rest of Europe Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 99. MEA Mydriatic Eyedrops, by Country USD Million (2018-2023)
  • Table 100. MEA Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 101. MEA Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 102. MEA Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 103. MEA Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 104. Middle East Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 105. Middle East Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 106. Middle East Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 107. Middle East Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 108. Africa Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 109. Africa Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 110. Africa Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 111. Africa Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 112. North America Mydriatic Eyedrops, by Country USD Million (2018-2023)
  • Table 113. North America Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 114. North America Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 115. North America Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 116. North America Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 117. United States Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 118. United States Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 119. United States Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 120. United States Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 121. Canada Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 122. Canada Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 123. Canada Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 124. Canada Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 125. Mexico Mydriatic Eyedrops, by Type USD Million (2018-2023)
  • Table 126. Mexico Mydriatic Eyedrops, by Application USD Million (2018-2023)
  • Table 127. Mexico Mydriatic Eyedrops, by Sales Channel USD Million (2018-2023)
  • Table 128. Mexico Mydriatic Eyedrops, by Disease Indication USD Million (2018-2023)
  • Table 129. Mydriatic Eyedrops Sales: by Type(K Units)
  • Table 130. Mydriatic Eyedrops Sales Atropine , by Region K Units (2018-2023)
  • Table 131. Mydriatic Eyedrops Sales Mydrilate (Cyclopentolate) , by Region K Units (2018-2023)
  • Table 132. Mydriatic Eyedrops Sales Homatropine , by Region K Units (2018-2023)
  • Table 133. Mydriatic Eyedrops Sales Mydriacyl (Tropicamide) , by Region K Units (2018-2023)
  • Table 134. Mydriatic Eyedrops Sales Phenylephrine , by Region K Units (2018-2023)
  • Table 135. Mydriatic Eyedrops Sales: by Application(K Units)
  • Table 136. Mydriatic Eyedrops Sales Infants , by Region K Units (2018-2023)
  • Table 137. Mydriatic Eyedrops Sales Children , by Region K Units (2018-2023)
  • Table 138. Mydriatic Eyedrops Sales Adults , by Region K Units (2018-2023)
  • Table 139. Mydriatic Eyedrops Sales: by Sales Channel(K Units)
  • Table 140. Mydriatic Eyedrops Sales Medical Stores , by Region K Units (2018-2023)
  • Table 141. Mydriatic Eyedrops Sales Pharmacy , by Region K Units (2018-2023)
  • Table 142. Mydriatic Eyedrops Sales Online Stores , by Region K Units (2018-2023)
  • Table 143. Mydriatic Eyedrops Sales: by Disease Indication(K Units)
  • Table 144. Mydriatic Eyedrops Sales Iritis Inflammation , by Region K Units (2018-2023)
  • Table 145. Mydriatic Eyedrops Sales Cyclitis , by Region K Units (2018-2023)
  • Table 146. Mydriatic Eyedrops Sales Cycloplegia , by Region K Units (2018-2023)
  • Table 147. Mydriatic Eyedrops Sales Others , by Region K Units (2018-2023)
  • Table 148. South America Mydriatic Eyedrops Sales, by Country K Units (2018-2023)
  • Table 149. South America Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 150. South America Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 151. South America Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 152. South America Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 153. Brazil Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 154. Brazil Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 155. Brazil Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 156. Brazil Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 157. Argentina Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 158. Argentina Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 159. Argentina Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 160. Argentina Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 161. Rest of South America Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 162. Rest of South America Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 163. Rest of South America Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 164. Rest of South America Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 165. Asia Pacific Mydriatic Eyedrops Sales, by Country K Units (2018-2023)
  • Table 166. Asia Pacific Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 167. Asia Pacific Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 168. Asia Pacific Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 169. Asia Pacific Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 170. China Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 171. China Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 172. China Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 173. China Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 174. Japan Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 175. Japan Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 176. Japan Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 177. Japan Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 178. India Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 179. India Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 180. India Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 181. India Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 182. South Korea Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 183. South Korea Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 184. South Korea Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 185. South Korea Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 186. Taiwan Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 187. Taiwan Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 188. Taiwan Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 189. Taiwan Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 190. Australia Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 191. Australia Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 192. Australia Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 193. Australia Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 194. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 195. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 196. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 197. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 198. Europe Mydriatic Eyedrops Sales, by Country K Units (2018-2023)
  • Table 199. Europe Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 200. Europe Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 201. Europe Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 202. Europe Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 203. Germany Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 204. Germany Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 205. Germany Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 206. Germany Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 207. France Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 208. France Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 209. France Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 210. France Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 211. Italy Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 212. Italy Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 213. Italy Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 214. Italy Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 215. United Kingdom Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 216. United Kingdom Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 217. United Kingdom Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 218. United Kingdom Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 219. Netherlands Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 220. Netherlands Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 221. Netherlands Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 222. Netherlands Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 223. Rest of Europe Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 224. Rest of Europe Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 225. Rest of Europe Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 226. Rest of Europe Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 227. MEA Mydriatic Eyedrops Sales, by Country K Units (2018-2023)
  • Table 228. MEA Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 229. MEA Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 230. MEA Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 231. MEA Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 232. Middle East Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 233. Middle East Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 234. Middle East Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 235. Middle East Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 236. Africa Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 237. Africa Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 238. Africa Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 239. Africa Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 240. North America Mydriatic Eyedrops Sales, by Country K Units (2018-2023)
  • Table 241. North America Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 242. North America Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 243. North America Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 244. North America Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 245. United States Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 246. United States Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 247. United States Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 248. United States Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 249. Canada Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 250. Canada Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 251. Canada Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 252. Canada Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 253. Mexico Mydriatic Eyedrops Sales, by Type K Units (2018-2023)
  • Table 254. Mexico Mydriatic Eyedrops Sales, by Application K Units (2018-2023)
  • Table 255. Mexico Mydriatic Eyedrops Sales, by Sales Channel K Units (2018-2023)
  • Table 256. Mexico Mydriatic Eyedrops Sales, by Disease Indication K Units (2018-2023)
  • Table 257. Mydriatic Eyedrops: by Type(USD/Units)
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Mydriatic Eyedrops: by Type(USD Million)
  • Table 270. Mydriatic Eyedrops Atropine , by Region USD Million (2025-2030)
  • Table 271. Mydriatic Eyedrops Mydrilate (Cyclopentolate) , by Region USD Million (2025-2030)
  • Table 272. Mydriatic Eyedrops Homatropine , by Region USD Million (2025-2030)
  • Table 273. Mydriatic Eyedrops Mydriacyl (Tropicamide) , by Region USD Million (2025-2030)
  • Table 274. Mydriatic Eyedrops Phenylephrine , by Region USD Million (2025-2030)
  • Table 275. Mydriatic Eyedrops: by Application(USD Million)
  • Table 276. Mydriatic Eyedrops Infants , by Region USD Million (2025-2030)
  • Table 277. Mydriatic Eyedrops Children , by Region USD Million (2025-2030)
  • Table 278. Mydriatic Eyedrops Adults , by Region USD Million (2025-2030)
  • Table 279. Mydriatic Eyedrops: by Sales Channel(USD Million)
  • Table 280. Mydriatic Eyedrops Medical Stores , by Region USD Million (2025-2030)
  • Table 281. Mydriatic Eyedrops Pharmacy , by Region USD Million (2025-2030)
  • Table 282. Mydriatic Eyedrops Online Stores , by Region USD Million (2025-2030)
  • Table 283. Mydriatic Eyedrops: by Disease Indication(USD Million)
  • Table 284. Mydriatic Eyedrops Iritis Inflammation , by Region USD Million (2025-2030)
  • Table 285. Mydriatic Eyedrops Cyclitis , by Region USD Million (2025-2030)
  • Table 286. Mydriatic Eyedrops Cycloplegia , by Region USD Million (2025-2030)
  • Table 287. Mydriatic Eyedrops Others , by Region USD Million (2025-2030)
  • Table 288. South America Mydriatic Eyedrops, by Country USD Million (2025-2030)
  • Table 289. South America Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 290. South America Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 291. South America Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 292. South America Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 293. Brazil Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 294. Brazil Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 295. Brazil Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 296. Brazil Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 297. Argentina Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 298. Argentina Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 299. Argentina Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 300. Argentina Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 301. Rest of South America Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 302. Rest of South America Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 303. Rest of South America Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 304. Rest of South America Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 305. Asia Pacific Mydriatic Eyedrops, by Country USD Million (2025-2030)
  • Table 306. Asia Pacific Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 307. Asia Pacific Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 308. Asia Pacific Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 309. Asia Pacific Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 310. China Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 311. China Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 312. China Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 313. China Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 314. Japan Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 315. Japan Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 316. Japan Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 317. Japan Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 318. India Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 319. India Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 320. India Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 321. India Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 322. South Korea Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 323. South Korea Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 324. South Korea Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 325. South Korea Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 326. Taiwan Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 327. Taiwan Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 328. Taiwan Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 329. Taiwan Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 330. Australia Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 331. Australia Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 332. Australia Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 333. Australia Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 334. Rest of Asia-Pacific Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 335. Rest of Asia-Pacific Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 336. Rest of Asia-Pacific Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 337. Rest of Asia-Pacific Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 338. Europe Mydriatic Eyedrops, by Country USD Million (2025-2030)
  • Table 339. Europe Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 340. Europe Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 341. Europe Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 342. Europe Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 343. Germany Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 344. Germany Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 345. Germany Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 346. Germany Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 347. France Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 348. France Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 349. France Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 350. France Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 351. Italy Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 352. Italy Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 353. Italy Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 354. Italy Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 355. United Kingdom Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 356. United Kingdom Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 357. United Kingdom Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 358. United Kingdom Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 359. Netherlands Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 360. Netherlands Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 361. Netherlands Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 362. Netherlands Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 363. Rest of Europe Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 364. Rest of Europe Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 365. Rest of Europe Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 366. Rest of Europe Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 367. MEA Mydriatic Eyedrops, by Country USD Million (2025-2030)
  • Table 368. MEA Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 369. MEA Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 370. MEA Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 371. MEA Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 372. Middle East Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 373. Middle East Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 374. Middle East Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 375. Middle East Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 376. Africa Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 377. Africa Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 378. Africa Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 379. Africa Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 380. North America Mydriatic Eyedrops, by Country USD Million (2025-2030)
  • Table 381. North America Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 382. North America Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 383. North America Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 384. North America Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 385. United States Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 386. United States Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 387. United States Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 388. United States Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 389. Canada Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 390. Canada Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 391. Canada Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 392. Canada Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 393. Mexico Mydriatic Eyedrops, by Type USD Million (2025-2030)
  • Table 394. Mexico Mydriatic Eyedrops, by Application USD Million (2025-2030)
  • Table 395. Mexico Mydriatic Eyedrops, by Sales Channel USD Million (2025-2030)
  • Table 396. Mexico Mydriatic Eyedrops, by Disease Indication USD Million (2025-2030)
  • Table 397. Mydriatic Eyedrops Sales: by Type(K Units)
  • Table 398. Mydriatic Eyedrops Sales Atropine , by Region K Units (2025-2030)
  • Table 399. Mydriatic Eyedrops Sales Mydrilate (Cyclopentolate) , by Region K Units (2025-2030)
  • Table 400. Mydriatic Eyedrops Sales Homatropine , by Region K Units (2025-2030)
  • Table 401. Mydriatic Eyedrops Sales Mydriacyl (Tropicamide) , by Region K Units (2025-2030)
  • Table 402. Mydriatic Eyedrops Sales Phenylephrine , by Region K Units (2025-2030)
  • Table 403. Mydriatic Eyedrops Sales: by Application(K Units)
  • Table 404. Mydriatic Eyedrops Sales Infants , by Region K Units (2025-2030)
  • Table 405. Mydriatic Eyedrops Sales Children , by Region K Units (2025-2030)
  • Table 406. Mydriatic Eyedrops Sales Adults , by Region K Units (2025-2030)
  • Table 407. Mydriatic Eyedrops Sales: by Sales Channel(K Units)
  • Table 408. Mydriatic Eyedrops Sales Medical Stores , by Region K Units (2025-2030)
  • Table 409. Mydriatic Eyedrops Sales Pharmacy , by Region K Units (2025-2030)
  • Table 410. Mydriatic Eyedrops Sales Online Stores , by Region K Units (2025-2030)
  • Table 411. Mydriatic Eyedrops Sales: by Disease Indication(K Units)
  • Table 412. Mydriatic Eyedrops Sales Iritis Inflammation , by Region K Units (2025-2030)
  • Table 413. Mydriatic Eyedrops Sales Cyclitis , by Region K Units (2025-2030)
  • Table 414. Mydriatic Eyedrops Sales Cycloplegia , by Region K Units (2025-2030)
  • Table 415. Mydriatic Eyedrops Sales Others , by Region K Units (2025-2030)
  • Table 416. South America Mydriatic Eyedrops Sales, by Country K Units (2025-2030)
  • Table 417. South America Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 418. South America Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 419. South America Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 420. South America Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 421. Brazil Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 422. Brazil Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 423. Brazil Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 424. Brazil Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 425. Argentina Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 426. Argentina Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 427. Argentina Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 428. Argentina Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 429. Rest of South America Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 430. Rest of South America Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 431. Rest of South America Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 432. Rest of South America Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 433. Asia Pacific Mydriatic Eyedrops Sales, by Country K Units (2025-2030)
  • Table 434. Asia Pacific Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 435. Asia Pacific Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 436. Asia Pacific Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 437. Asia Pacific Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 438. China Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 439. China Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 440. China Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 441. China Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 442. Japan Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 443. Japan Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 444. Japan Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 445. Japan Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 446. India Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 447. India Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 448. India Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 449. India Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 450. South Korea Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 451. South Korea Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 452. South Korea Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 453. South Korea Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 454. Taiwan Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 455. Taiwan Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 456. Taiwan Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 457. Taiwan Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 458. Australia Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 459. Australia Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 460. Australia Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 461. Australia Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 462. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 463. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 464. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 465. Rest of Asia-Pacific Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 466. Europe Mydriatic Eyedrops Sales, by Country K Units (2025-2030)
  • Table 467. Europe Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 468. Europe Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 469. Europe Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 470. Europe Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 471. Germany Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 472. Germany Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 473. Germany Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 474. Germany Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 475. France Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 476. France Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 477. France Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 478. France Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 479. Italy Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 480. Italy Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 481. Italy Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 482. Italy Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 483. United Kingdom Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 484. United Kingdom Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 485. United Kingdom Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 486. United Kingdom Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 487. Netherlands Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 488. Netherlands Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 489. Netherlands Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 490. Netherlands Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 491. Rest of Europe Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 492. Rest of Europe Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 493. Rest of Europe Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 494. Rest of Europe Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 495. MEA Mydriatic Eyedrops Sales, by Country K Units (2025-2030)
  • Table 496. MEA Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 497. MEA Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 498. MEA Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 499. MEA Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 500. Middle East Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 501. Middle East Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 502. Middle East Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 503. Middle East Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 504. Africa Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 505. Africa Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 506. Africa Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 507. Africa Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 508. North America Mydriatic Eyedrops Sales, by Country K Units (2025-2030)
  • Table 509. North America Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 510. North America Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 511. North America Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 512. North America Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 513. United States Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 514. United States Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 515. United States Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 516. United States Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 517. Canada Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 518. Canada Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 519. Canada Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 520. Canada Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 521. Mexico Mydriatic Eyedrops Sales, by Type K Units (2025-2030)
  • Table 522. Mexico Mydriatic Eyedrops Sales, by Application K Units (2025-2030)
  • Table 523. Mexico Mydriatic Eyedrops Sales, by Sales Channel K Units (2025-2030)
  • Table 524. Mexico Mydriatic Eyedrops Sales, by Disease Indication K Units (2025-2030)
  • Table 525. Mydriatic Eyedrops: by Type(USD/Units)
  • Table 526. Research Programs/Design for This Report
  • Table 527. Key Data Information from Secondary Sources
  • Table 528. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Mydriatic Eyedrops: by Type USD Million (2018-2023)
  • Figure 5. Global Mydriatic Eyedrops: by Application USD Million (2018-2023)
  • Figure 6. Global Mydriatic Eyedrops: by Sales Channel USD Million (2018-2023)
  • Figure 7. Global Mydriatic Eyedrops: by Disease Indication USD Million (2018-2023)
  • Figure 8. South America Mydriatic Eyedrops Share (%), by Country
  • Figure 9. Asia Pacific Mydriatic Eyedrops Share (%), by Country
  • Figure 10. Europe Mydriatic Eyedrops Share (%), by Country
  • Figure 11. MEA Mydriatic Eyedrops Share (%), by Country
  • Figure 12. North America Mydriatic Eyedrops Share (%), by Country
  • Figure 13. Global Mydriatic Eyedrops: by Type K Units (2018-2023)
  • Figure 14. Global Mydriatic Eyedrops: by Application K Units (2018-2023)
  • Figure 15. Global Mydriatic Eyedrops: by Sales Channel K Units (2018-2023)
  • Figure 16. Global Mydriatic Eyedrops: by Disease Indication K Units (2018-2023)
  • Figure 17. South America Mydriatic Eyedrops Share (%), by Country
  • Figure 18. Asia Pacific Mydriatic Eyedrops Share (%), by Country
  • Figure 19. Europe Mydriatic Eyedrops Share (%), by Country
  • Figure 20. MEA Mydriatic Eyedrops Share (%), by Country
  • Figure 21. North America Mydriatic Eyedrops Share (%), by Country
  • Figure 22. Global Mydriatic Eyedrops: by Type USD/Units (2018-2023)
  • Figure 23. Global Mydriatic Eyedrops share by Players 2023 (%)
  • Figure 24. Global Mydriatic Eyedrops share by Players (Top 3) 2023(%)
  • Figure 25. Global Mydriatic Eyedrops share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. Novartis AG (Switzerland) Revenue: by Geography 2023
  • Figure 29. Alcon Laboratories (M) Sdn Bhd (Malaysia) Revenue, Net Income and Gross profit
  • Figure 30. Alcon Laboratories (M) Sdn Bhd (Malaysia) Revenue: by Geography 2023
  • Figure 31. Santen Pharmaceutical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Santen Pharmaceutical Co., Ltd. (Japan) Revenue: by Geography 2023
  • Figure 33. Visine (Johnson & Johnson Consumer Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 34. Visine (Johnson & Johnson Consumer Inc.) (United States) Revenue: by Geography 2023
  • Figure 35. Akorn Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Akorn Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Hikma Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Hikma Pharmaceuticals (United Kingdom) Revenue: by Geography 2023
  • Figure 39. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Fresenius Kabi (Germany) Revenue: by Geography 2023
  • Figure 41. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 42. Cipla Limited (India) Revenue: by Geography 2023
  • Figure 43. Ocuphire Pharma, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Ocuphire Pharma, Inc. (United States) Revenue: by Geography 2023
  • Figure 45. Eyekare Kilitch Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 46. Eyekare Kilitch Ltd. (India) Revenue: by Geography 2023
  • Figure 47. MOLBASE (Shanghai) Biotechnology Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 48. MOLBASE (Shanghai) Biotechnology Co., Ltd (China) Revenue: by Geography 2023
  • Figure 49. Global Mydriatic Eyedrops: by Type USD Million (2025-2030)
  • Figure 50. Global Mydriatic Eyedrops: by Application USD Million (2025-2030)
  • Figure 51. Global Mydriatic Eyedrops: by Sales Channel USD Million (2025-2030)
  • Figure 52. Global Mydriatic Eyedrops: by Disease Indication USD Million (2025-2030)
  • Figure 53. South America Mydriatic Eyedrops Share (%), by Country
  • Figure 54. Asia Pacific Mydriatic Eyedrops Share (%), by Country
  • Figure 55. Europe Mydriatic Eyedrops Share (%), by Country
  • Figure 56. MEA Mydriatic Eyedrops Share (%), by Country
  • Figure 57. North America Mydriatic Eyedrops Share (%), by Country
  • Figure 58. Global Mydriatic Eyedrops: by Type K Units (2025-2030)
  • Figure 59. Global Mydriatic Eyedrops: by Application K Units (2025-2030)
  • Figure 60. Global Mydriatic Eyedrops: by Sales Channel K Units (2025-2030)
  • Figure 61. Global Mydriatic Eyedrops: by Disease Indication K Units (2025-2030)
  • Figure 62. South America Mydriatic Eyedrops Share (%), by Country
  • Figure 63. Asia Pacific Mydriatic Eyedrops Share (%), by Country
  • Figure 64. Europe Mydriatic Eyedrops Share (%), by Country
  • Figure 65. MEA Mydriatic Eyedrops Share (%), by Country
  • Figure 66. North America Mydriatic Eyedrops Share (%), by Country
  • Figure 67. Global Mydriatic Eyedrops: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Novartis AG (Switzerland)
  • Alcon Laboratories (M) Sdn Bhd (Malaysia)
  • Santen Pharmaceutical Co., Ltd. (Japan)
  • Visine (Johnson & Johnson Consumer Inc.) (United States)
  • Akorn Inc. (United States)
  • Hikma Pharmaceuticals (United Kingdom)
  • Fresenius Kabi (Germany)
  • Cipla Limited (India)
  • Ocuphire Pharma, Inc. (United States)
  • Eyekare Kilitch Ltd. (India)
  • MOLBASE (Shanghai) Biotechnology Co., Ltd (China)
Additional players considered in the study are as follows:
Manus Aktteva Biopharma LLP (India) , Iwaki Seiyaku Co., Ltd (Japan)
Select User Access Type

Key Highlights of Report


Apr 2024 201 Pages 95 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Mydriatic Eyedrops Market Quantitative research analysis
Global Mydriatic Eyedrops Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • Proper Labeling and Packaging Mydriatic Eyedrops for Effective Use

Know More About Global Mydriatic Eyedrops Market Report?

Have a Query? Click Here

Other Related Reports

Surgical Sealants and Adhesives Comprehensive Study by Type (Natural/Biological Surgical Sealants & Adhesives, Synthetic & Semisynthetic Sealants and Adhesives), Application (Central Nervous System S...
$ 3750
Pre-Clinicals Stage Cardiovascular Pipeline Products Comprehensive Study by Type (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Surgery Devices, Peripheral Vascular Device...
$ 3750
HIV Test Kits Comprehensive Study by Type (Antibody Tests, RNA (Viral load) Test, Antibody-antigen Test), Application (Diagnostic Centers, Hospitals, Home Use), Sales Channel (Online Sale, Offline Sa...
$ 3450
Alcohol Cottons Comprehensive Study by Type (Alcohol Cotton Balls, Alcohol Cotton Swabs), End-users (Hospital, Clinic, Home, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Onl...
$ 3500
Safety Mask Comprehensive Study by Type (Disposable, Reusable), Distribution Channel (Online, Offline), Size (Large, Small, Medium), End-User (Individual, Hospitals & Clinics, Industry, Others), Leve...
$ 3650
Animal Pharm Antibiotics Comprehensive Study by Type (Feed Enzymes, Organic Acids, Phyochemicals, Prebiotics, Probiotics), Application (Broilers, Pigs, Cows, Others), Mode of Delivery (Premixes, Oral...
$ 3650